UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 258

Sortiert nach

The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)

EBioMedicine, 2020-08, Vol.58, p.102887-102887, Article 102887

2020

Volltextzugriff (PDF)

Not all COVID-19 pandemic waves are alike

Clinical microbiology and infection, 2021-07, Vol.27 (7), p.1040.e7-1040.e10

2021

Volltextzugriff (PDF)

Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study

Scientific reports, 2024-01, Vol.14 (1), p.172-172, Article 172

2024

Volltextzugriff (PDF)

Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjögren’s syndrome: A critical review

Frontiers in immunology, 2022-10, Vol.13, p.1003054-1003054

2022

Volltextzugriff (PDF)

Effect of bosentan in pulmonary hypertension development in systemic sclerosis patients with digital ulcers

PloS one, 2020-12, Vol.15 (12), p.e0243651-e0243651

2020

Volltextzugriff (PDF)

"The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica"

PloS one, 2021-09, Vol.16 (9), p.e0255131-e0255131

2021

Volltextzugriff (PDF)

Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis

Medicina (Kaunas, Lithuania), 2024-02, Vol.60 (3), p.360

2024

Volltextzugriff (PDF)

Initial Treatment with Biological Therapy in Rheumatoid Arthritis

Journal of clinical medicine, 2023-12, Vol.13 (1), p.48

2023

Volltextzugriff (PDF)

Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data

Seminars in arthritis and rheumatism, 2022-08, Vol.55, p.152017, Article 152017

2022

Volltextzugriff (PDF)

Phenotypic and Functional Consequences of PLT Binding to Monocytes and Its Association with Clinical Features in SLE

International journal of molecular sciences, 2021-04, Vol.22 (9), p.4719

2021

Volltextzugriff (PDF)

Increase of Circulating Monocyte-Platelet Conjugates in Rheumatoid Arthritis Responders to IL-6 Blockage

International journal of molecular sciences, 2022-05, Vol.23 (10), p.5748

2022

Volltextzugriff (PDF)

Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review

Clinical drug investigation, 2023-08, Vol.43 (8), p.579-593

2023

Volltextzugriff (PDF)

Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis

Arthritis research & therapy, 2023-11, Vol.25 (1), p.226-226, Article 226

2023

Volltextzugriff (PDF)

Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients?

Journal of clinical medicine, 2024-04, Vol.13 (8), p.2355

2024

Volltextzugriff (PDF)

Satisfaction and effectiveness of switching from intravenous to subcutaneous belimumab treatment in daily clinical practice

Lupus, 2024-04, Vol.33 (5), p.481-489

2024

Volltextzugriff (PDF)

Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort

Rheumatic & musculoskeletal diseases open, 2024-04, Vol.10 (2), p.e004173

2024

Volltextzugriff (PDF)

Rosai–Dorfman disease: Ultrasonography and histopathology study of a soft tissue mass in the forearm

Reumatología clinica, 2020-03, Vol.16 (2), p.174-176

2020

Volltextzugriff (PDF)

Metabolomics profiling predicts outcome of tocilizumab in rheumatoid arthritis: an exploratory study

Metabolomics, 2021-09, Vol.17 (9), p.74-74, Article 74

2021

Volltextzugriff (PDF)

Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort

Clinical immunology (Orlando, Fla.), 2021-02, Vol.223, p.108631-108631, Article 108631

2021

Volltextzugriff (PDF)

Crystal-induced oligoarthritis triggered by pembrolizumab, an immune checkpoint inhibitor

Joint, bone, spine : revue du rhumatisme, 2018-10, Vol.85 (5), p.647-648

2018

Volltextzugriff (PDF)

Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis

Pharmaceutics, 2022-09, Vol.14 (9), p.1942

2022

Volltextzugriff (PDF)

Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis

PloS one, 2015-04, Vol.10 (4), p.e0122088-e0122088

2015

Volltextzugriff (PDF)

Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib

Clinical rheumatology, 2023-12, Vol.42 (12), p.3225-3235

2023

Volltextzugriff (PDF)

A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis

Frontiers in immunology, 2019, Vol.10, p.1459-1459

2019

Volltextzugriff (PDF)

Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2

Medicine (Baltimore), 2021-05, Vol.100 (19), p.e25923-e25923

2021

Volltextzugriff (PDF)

1 – 25 von 258

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(195)
Mit Volltextzugriff
(217)

Publikationsform

Artikel
(252)
Berichte
(6)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(146)
Life Sciences & Biomedicine
(140)
Humans
(110)
Rheumatology
(99)
Male
(61)
Rheumatoid Arthritis
(61)
Female
(58)
Middle Aged
(44)
Aged
(41)
Adult
(32)
Arthritis, Rheumatoid - Drug Therapy
(26)
Patients
(26)
Artritis Reumatoide
(25)
Aged, 80 And Over
(23)
General & Internal Medicine
(22)
Medicine
(22)
Medicine, General & Internal
(22)
Antirheumatic Agents - Therapeutic Use
(20)
Arthritis
(18)
Medicine & Public Health
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)

Not all COVID-19 pandemic waves are alike

Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study

Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjögren’s syndrome: A critical review

Effect of bosentan in pulmonary hypertension development in systemic sclerosis patients with digital ulcers

"The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica"

Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis

Initial Treatment with Biological Therapy in Rheumatoid Arthritis

Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data

Phenotypic and Functional Consequences of PLT Binding to Monocytes and Its Association with Clinical Features in SLE

Increase of Circulating Monocyte-Platelet Conjugates in Rheumatoid Arthritis Responders to IL-6 Blockage

Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review

Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis

Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients?

Satisfaction and effectiveness of switching from intravenous to subcutaneous belimumab treatment in daily clinical practice

Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort

Rosai–Dorfman disease: Ultrasonography and histopathology study of a soft tissue mass in the forearm

Metabolomics profiling predicts outcome of tocilizumab in rheumatoid arthritis: an exploratory study

Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort

Crystal-induced oligoarthritis triggered by pembrolizumab, an immune checkpoint inhibitor

Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis

Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis

Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib

A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis

Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2

Suchergebnisse filtern